For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
2
views
0
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis.

      Author(s):
      Publication date:
      Journal: Drug Design, Development and Therapy
      Publisher: Informa UK Ltd.
      Keywords: ranibizumab, bevacizumab, VEGF, aflibercept, meta-analysis, age-related macular degeneration

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Age-related macular degeneration (AMD) is the main cause of blindness. Anti-vascular endothelial growth factor is used to prevent further neovascularization due to wet AMD. The purpose of this systematic review was to investigate the effect and protocol of anti-vascular endothelial growth factor treatment on wet AMD.

          Related collections

          Author and article information

          Journal
          DOI:: 10.2147/DDDT.S86269
          PMC ID:: 4592052
          PubMed ID:: 26451092

          Keywords: ranibizumab,bevacizumab,VEGF,aflibercept,meta-analysis,age-related macular degeneration
          Data availability:
          Keywords: ranibizumab, bevacizumab, VEGF, aflibercept, meta-analysis, age-related macular degeneration

          Comments

          Comment on this article

          scite_